Cubist Pharmaceuticals, Inc. (CBST) Tops Q2 EPS by 23c
Tweet Send to a FriendGet Alerts CBST Hot Sheet
Price: $56.11 --0%
Revenue Growth %: +8.6%
Financial Fact:
(Loss) income before income taxes: 3.59M
Today's EPS Names:
SFL, RL, PERY, More
Revenue Growth %: +8.6%
Financial Fact:
(Loss) income before income taxes: 3.59M
Today's EPS Names:
SFL, RL, PERY, More
Trade CBST Now!
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q2 EPS of $0.68, $0.23 better than the analyst estimate of $0.45. Revenue for the quarter came in at $230.6 million versus the consensus estimate of $226.05 million.
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Semtech Corp (SMTC) Reports In-Line Q1 EPS, Offers Q2 Guidance
- Staples, Inc. (SPLS) Misses Q1 EPS by 1c
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
